Rockefeller Capital Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,754
| Closed | -$638K | – | 1651 |
|
|
2024
Q1 | $638K | Buy |
13,754
+1,902
| +16% | +$88.3K | ﹤0.01% | 1395 |
|
|
2023
Q4 | $801K | Buy |
11,852
+337
| +3% | +$22.8K | ﹤0.01% | 1221 |
|
|
2023
Q3 | $834K | Buy |
11,515
+1,578
| +16% | +$114K | ﹤0.01% | 1147 |
|
|
2023
Q2 | $739K | Sell |
9,937
-2,430
| -20% | -$181K | ﹤0.01% | 1195 |
|
|
2023
Q1 | $657K | Buy |
12,367
+8
| +0.1% | +$425 | ﹤0.01% | 1231 |
|
|
2022
Q4 | $834K | Sell |
12,359
-2,403
| -16% | -$162K | ﹤0.01% | 1080 |
|
|
2022
Q3 | $1.84M | Sell |
14,762
-462
| -3% | -$57.6K | 0.01% | 782 |
|
|
2022
Q2 | $1.45M | Buy |
15,224
+1,341
| +10% | +$127K | 0.01% | 872 |
|
|
2022
Q1 | $2.24M | Buy |
13,883
+3,869
| +39% | +$623K | 0.01% | 766 |
|
|
2021
Q4 | $3.33M | Buy |
10,014
+3,392
| +51% | +$1.13M | 0.02% | 664 |
|
|
2021
Q3 | $3.07M | Buy |
+6,622
| New | +$3.07M | 0.02% | 624 |
|